Search Results 1341-1350 of 18302 for anaphylaxis

1. Bronchiolitis - Symptoms and causes - Mayo Clinic

   Bronchiolitis is a common lung infection in young children and infants. It causes swelling and irritation and a buildup of mucus in the small airways of the ...

2. Study of DF9001 in Patients With Advanced Solid Tumors - Mayo Clinic

   ... anaphylaxis, or uncontrolled asthma (ie, 3 or more features of partly controlled asthma). 11. Persisting toxicity related to prior therapy >Grade 1 NCI ...

3. Asthma attack - Doctors and departments - Mayo Clinic

   Learn how to recognize when you need to use quick-relief treatment or get emergency care.

4. Churg-Strauss syndrome - Symptoms & causes - Mayo Clinic

   Eosinophilic granulomatosis with polyangiitis is a rare blood vessel disease that may cause breathing trouble, face pain and a runny nose.

5. Study of INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma - Mayo Clinic

   History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins;; Known hypersensitivity ...

6. A Study to Evaluate Safety of Long-term AL001 Dosing in FTD Patients - Mayo Clinic

   Participation eligibility · Known history of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric, human, or humanized antibodies or ...

7. My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors - Mayo Clinic

   History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins; Known hypersensitivity ...

8. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-tumor Activity of LYT-200 Alone and Combined with Chemotherapy or Tislelizumab to Treat Patients with Metastatic Solid Tumors - Mayo Clinic

   History of severe allergic, anaphylactic, or other hypersensitivity reactions to chimeric or humanized antibodies or fusion proteins. Significant vascular ...

9. Phase 1/2a Clinical Trial Of PR001 (LY3884961) In Patients With Parkinson's Disease With At Least One GBA1 Mutation (PROPEL)

   ... ;; History of severe allergic or anaphylactic reactions. History of hypersensitivity to any inactive ingredient of the IP or protocol-required ...

10. A Phase 2, Multicenter, Study of Ficlatuzumab Plus Erlotinib Versus Placebo Plus Erlotinib in Subjects Who Have Previously Untreated Metastatic, EGFR-mutated Non-small Cell Lung Cancer (NSCLC) and BDX004 Positive Label - Mayo Clinic

    History of severe allergic or anaphylactic reactions or hypersensitivity to recombinant proteins or excipients in the investigational agent or erlotinib.